Cardiovascular Considerations of Experimental Hydroxychloroquine Therapy on Patients Diagnosed With COVID-19: A Case Series ReviewCardiology Published on 2020-07-122022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory distress acute respiratory syndrome adverse effect antimalarial ARDS Asymptomatic benefit bradycardia cardiovascular caused Community coronavirus coronavirus disease COVID 19 COVID-19 Efficacy Evidence HCQ heterogeneous nature Hydroxychloroquine lack medication pandemic Patient prolonged qt Randomized controlled trials review risk-benefit SARS-CoV-2 Sery Side effect Symptom syndrome the disease therapeutic therapeutic effect virulence while [DOI] 10.7759/cureus.9151 PMC 바로가기 [Article Type] Cardiology
Cardiovascular manifestations in severe and critical patients with COVID ‐19Clinical Investigations Published on 2020-06-202022-10-31 Journal: Clinical Cardiology [Category] COVID-19, [키워드] acute respiratory syndrome Admission analyzed arrythmia Atrial fibrillation blood pressure bradycardia cardiac function cardiac injury cardiac marker cardiovascular Cardiovascular manifestations cardiovascular system Clinical outcome Corona coronavirus COVID COVID‐19 COVID‐19 infection COVID‐19 patient COVID‐19 Critical Critical case critical cases critical status D‐dimer diabetes diagnosed enrolled Factor FIVE heart failure Hospitalization Hypotension independent risk factor Infection Inflammatory Intervention less male manifestation monitoring myocardial injury occurred Occurrence organ Patient patients Pneumonia Result SARS‐CoV‐2 Seven Severe case Severe patient severity significantly higher Sinus tachycardia suffered systemically Tachycardia TnI Treatment troponin ventricular virulent vital sign [DOI] 10.1002/clc.23384 PMC 바로가기 [Article Type] Clinical Investigations
Bradycardia in Patients With COVID-19: A Calm Before the Storm?Cardiology Published on 2020-06-132022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory syndrome Admission arrhythmia association bradycardia cardiac cardiovascular case sery Comorbidity contributing to Corona Virus Disease coronavirus coronavirus disease correlation COVID-19 Cytokine release syndrome (CRS) Cytokine storm demographic described dexmedetomidine ECG Effects electrocardiogram EpiC Fahrenheit females FIVE Health heart rate ICU Infection Inflammatory knowledge Laboratory laboratory-confirmed lowest maintain male manifestation maximum body temperature mean arterial pressure medication multifactorial network nine pacemaker cells Patient pro-inflammatory cytokine Prolonged propofol QTc interval ranged receiving reported required retrospective SARS-CoV-2 sars-cov-2 (severe acute respiratory syndrome coronavirus -2) severe hypoxia Surveillance Transient Treatment triggers Two patient university Vasopressor [DOI] 10.7759/cureus.8599 PMC 바로가기 [Article Type] Cardiology
Clinical analysis of sinus bradycardia in patients with severe COVID-19 pneumoniaResearch Letter Published on 2020-05-262022-11-01 Journal: Critical Care [Category] Coronavirus, MERS, SARS, [키워드] ACE2 Analysis bradycardia clinical clinical manifestation COVID-19 Patient Severe COVID-19 pneumonia severe pneumonia sinus bradycardia [DOI] 10.1186/s13054-020-02933-3 PMC 바로가기 [Article Type] Research Letter
Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome as a Presentation of Coronavirus Disease 2019Emergency Medicine Published on 2020-04-242022-10-31 Journal: Cureus [Category] COVID-19, [키워드] av nodal blockers blockade bradycardia brash syndrome Coronavirus disease 2019 COVID-19 end-organ damage failure global pandemic hyperkalemia novel coronavirus disease predominant presentation renal renal failure Respiratory failure sars-cov-2 (severe acute respiratory syndrome coronavirus -2) Shock syndrome triggered while [DOI] 10.7759/cureus.7816 PMC 바로가기 [Article Type] Emergency Medicine